Details
Stereochemistry | ACHIRAL |
Molecular Formula | C13H10N2O3S |
Molecular Weight | 274.295 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(=O)(=O)C1=CC2=C(C=C1)N=C(N2)C3=CC=CC=C3
InChI
InChIKey=UVCJGUGAGLDPAA-UHFFFAOYSA-N
InChI=1S/C13H10N2O3S/c16-19(17,18)10-6-7-11-12(8-10)15-13(14-11)9-4-2-1-3-5-9/h1-8H,(H,14,15)(H,16,17,18)
DescriptionSources: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=611798eb-4004-40e8-b7ff-345136253975Curator's Comment: description was created based on several sources, including:
http://www.ncbi.nlm.nih.gov/pubmed/23112351
Sources: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=611798eb-4004-40e8-b7ff-345136253975
Curator's Comment: description was created based on several sources, including:
http://www.ncbi.nlm.nih.gov/pubmed/23112351
Ensulizole (INN) (phenylbenzimidazole sulfonic acid) is a common sunscreen agent. In 1999, the United States Food and Drug Administration regulated that the name ensulizole be used on sunscreen labels in the United States. It is a selective UVB filter, allowing almost all UVA transmission. The scope of UVB is 290 to 340 nanometers whereas the UVA range is 320 to 400 nanometers. For better UVA protection, it must be paired with avobenzone, titanium dioxide, or zinc oxide; outside of the United States it can also be paired with a UV absorber of the Tinosorb or Mexoryl types. Because is water-soluble, it has the characteristic of feeling lighter on skin. As such, it is often used in sunscreen lotions or moisturizers whose aesthetic goal is a non-greasy finish. The free acid is poorly soluble in water, so it is only used as its soluble salts
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: ultraviolet B Sources: http://www.ncbi.nlm.nih.gov/pubmed/23112351 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | ALOE SUNSCREEN Approved UseUnknown Launch Date2011 |
Doses
Dose | Population | Adverse events |
---|---|---|
10 % single, topical Studied dose |
healthy, ADULT Health Status: healthy Age Group: ADULT Sex: M Food Status: UNKNOWN Sources: |
Disc. AE: Allergic contact dermatitis... AEs leading to discontinuation/dose reduction: Allergic contact dermatitis (100%) Sources: |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Allergic contact dermatitis | 100% Disc. AE |
10 % single, topical Studied dose |
healthy, ADULT Health Status: healthy Age Group: ADULT Sex: M Food Status: UNKNOWN Sources: |
PubMed
Title | Date | PubMed |
---|---|---|
Photophysical and photochemical studies of 2-phenylbenzimidazole and UVB sunscreen 2-phenylbenzimidazole-5-sulfonic acid. | 2002 Feb |
|
Sensitive sequential-injection system for the determination of 2-phenylbenzimidazole-5-sulphonic acid in human urine samples using on-line solid-phase extraction coupled with fluorimetric detection. | 2003 Mar 1 |
|
Multiclass determination of sunscreen chemicals in water samples by liquid chromatography-tandem mass spectrometry. | 2008 Feb 15 |
|
The sunscreen agent 2-phenylbenzimidazole-5-sulfonic acid photosensitizes the formation of oxidized guanines in cellulo after UV-A or UV-B exposure. | 2010 Oct |
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C851
Created by
admin on Wed Apr 02 07:04:57 GMT 2025 , Edited by admin on Wed Apr 02 07:04:57 GMT 2025
|
||
|
CFR |
21 CFR 352.20
Created by
admin on Wed Apr 02 07:04:57 GMT 2025 , Edited by admin on Wed Apr 02 07:04:57 GMT 2025
|
||
|
CFR |
21 CFR 352.10
Created by
admin on Wed Apr 02 07:04:57 GMT 2025 , Edited by admin on Wed Apr 02 07:04:57 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB11115
Created by
admin on Wed Apr 02 07:04:57 GMT 2025 , Edited by admin on Wed Apr 02 07:04:57 GMT 2025
|
PRIMARY | |||
|
m4917
Created by
admin on Wed Apr 02 07:04:57 GMT 2025 , Edited by admin on Wed Apr 02 07:04:57 GMT 2025
|
PRIMARY | Merck Index | ||
|
9YQ9DI1W42
Created by
admin on Wed Apr 02 07:04:57 GMT 2025 , Edited by admin on Wed Apr 02 07:04:57 GMT 2025
|
PRIMARY | |||
|
9YQ9DI1W42
Created by
admin on Wed Apr 02 07:04:57 GMT 2025 , Edited by admin on Wed Apr 02 07:04:57 GMT 2025
|
PRIMARY | |||
|
CHEMBL1987518
Created by
admin on Wed Apr 02 07:04:57 GMT 2025 , Edited by admin on Wed Apr 02 07:04:57 GMT 2025
|
PRIMARY | |||
|
3179
Created by
admin on Wed Apr 02 07:04:57 GMT 2025 , Edited by admin on Wed Apr 02 07:04:57 GMT 2025
|
PRIMARY | |||
|
SUB01893MIG
Created by
admin on Wed Apr 02 07:04:57 GMT 2025 , Edited by admin on Wed Apr 02 07:04:57 GMT 2025
|
PRIMARY | |||
|
27503-81-7
Created by
admin on Wed Apr 02 07:04:57 GMT 2025 , Edited by admin on Wed Apr 02 07:04:57 GMT 2025
|
PRIMARY | |||
|
DTXSID3038852
Created by
admin on Wed Apr 02 07:04:57 GMT 2025 , Edited by admin on Wed Apr 02 07:04:57 GMT 2025
|
PRIMARY | |||
|
7995
Created by
admin on Wed Apr 02 07:04:57 GMT 2025 , Edited by admin on Wed Apr 02 07:04:57 GMT 2025
|
PRIMARY | |||
|
100000087263
Created by
admin on Wed Apr 02 07:04:57 GMT 2025 , Edited by admin on Wed Apr 02 07:04:57 GMT 2025
|
PRIMARY | |||
|
1530809
Created by
admin on Wed Apr 02 07:04:57 GMT 2025 , Edited by admin on Wed Apr 02 07:04:57 GMT 2025
|
PRIMARY | |||
|
33919
Created by
admin on Wed Apr 02 07:04:57 GMT 2025 , Edited by admin on Wed Apr 02 07:04:57 GMT 2025
|
PRIMARY | |||
|
C83690
Created by
admin on Wed Apr 02 07:04:57 GMT 2025 , Edited by admin on Wed Apr 02 07:04:57 GMT 2025
|
PRIMARY | |||
|
248-502-0
Created by
admin on Wed Apr 02 07:04:57 GMT 2025 , Edited by admin on Wed Apr 02 07:04:57 GMT 2025
|
PRIMARY | |||
|
Ensulizole
Created by
admin on Wed Apr 02 07:04:57 GMT 2025 , Edited by admin on Wed Apr 02 07:04:57 GMT 2025
|
PRIMARY | |||
|
LL-23
Created by
admin on Wed Apr 02 07:04:57 GMT 2025 , Edited by admin on Wed Apr 02 07:04:57 GMT 2025
|
PRIMARY | |||
|
13714
Created by
admin on Wed Apr 02 07:04:57 GMT 2025 , Edited by admin on Wed Apr 02 07:04:57 GMT 2025
|
PRIMARY | RxNorm | ||
|
C499767
Created by
admin on Wed Apr 02 07:04:57 GMT 2025 , Edited by admin on Wed Apr 02 07:04:57 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)